Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$5,659,213
+$194,024 QoQ
Shares Held
22,283
-0.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.78%
of 13F equity value
Holder Rank
#1,528
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EagleClaw Capital Managment, LLC holds $45,392,435 across 12 Drug Manufacturers - General names. JNJ ranks #2 (12.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
71,774 | $18,061,209 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
22,283 | $5,659,213 | |
| 3 | MRK |
Merck & Co., Inc.
|
30,088 | $3,866,308 | |
| 4 | NVS |
Novartis AG
|
23,712 | $3,716,144 | |
| 5 | PFE |
Pfizer Inc
|
153,401 | $3,693,896 | |
| 6 | NVO |
Novo Nordisk A S
|
63,650 | $3,051,381 | |
| 7 | LLY |
ELI LILLY & Co
|
1,772 | $2,125,390 | |
| 8 | SNY |
Sanofi
|
45,410 | $1,937,190 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,659,213 | 22,283 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $5,465,189 | 22,358 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $4,821,107 | 23,296 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $4,305,637 | 23,221 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,965,794 | 19,416 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $3,246,815 | 19,578 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $2,877,359 | 19,896 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $2,976,393 | 18,366 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $2,708,490 | 18,531 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,931,418 | 18,531 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,810,504 | 17,931 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,743,692 | 17,616 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,899,248 | 17,516 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,769,230 | 17,866 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $3,144,546 | 17,801 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $2,907,971 | 17,801 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $3,211,333 | 18,091 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $3,237,283 | 18,266 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,137,594 | 18,341 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,828,834 | 17,516 | Shares | Sole | 2021-12-02 | |
| 2021-06-30 | $2,830,068 | 17,179 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,525,895 | 15,369 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $2,379,428 | 15,119 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,303,024 | 15,469 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $2,208,453 | 15,704 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,541,168 | 19,379 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||